Antares Vision SpA (AV) AI Stock Analysis

• Market Cap: €249.59M
• Dividend Yield: N/A
• Average Volume (3M): 119.25K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.67
• Revenue Growth: -1.20%
• EPS Growth: N/A
• Country: IT
• Employees: 1,120
• Sector: Industrials
• Sector Strength: 79
• Industry: Security & Protection Services
• EPS (TTM): -0.27
• Shares Outstanding: 70,891,800
• 10 Day Avg. Volume: 83,030
• 30 Day Avg. Volume: 119,251
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): 0.00
• Price to Cash Flow (P/CF): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €4.35
• Price Target Upside: 23.93% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

Antares Vision SpA faces significant financial challenges, including declining revenues and profitability pressures, which are the most significant factors impacting its stock score. While there are improvements in cash flow management, the company's valuation metrics reflect financial instability. Technical analysis presents mixed signals, with potential for short-term price reversals but no clear upward momentum. Overall, the stock score reflects a cautious outlook, heavily influenced by the company's current financial difficulties.

Positive Factors

Order Intake Growth

Order intake increased by 9% year-over-year, with strong growth in Europe and Italy, enhancing visibility on future estimates.

Strategic Initiatives

Antares Vision's strategic initiatives, including product standardization and cost savings, have driven operational efficiency and outperformed cash flow expectations.

Negative Factors

Market Risks

The US market is a downside risk due to stagnation and introduced tariffs, with potential impacts on margins.

Regional Slowdown

The slowdown in the US market, affecting both Life Sciences & Cosmetics and FMCG segments, poses a downside risk to valuation.

Antares Vision SpA Business Overview & Revenue Model

Company Description

Antares Vision SpA (AV) is a global leader in providing inspection systems, track and trace solutions, and smart data management for the pharmaceutical, food and beverage, and cosmetics industries. The company is headquartered in Italy and is known for its innovative technology that ensures product quality and safety while enhancing transparency across the supply chain.

How the Company Makes Money

Antares Vision SpA generates revenue primarily through the sale of its high-tech inspection systems and track and trace solutions. These systems are crucial for manufacturers in ensuring product integrity and regulatory compliance. The company also offers software solutions for data management that help businesses optimize their operations and supply chain efficiency. Key revenue streams include direct sales of equipment and software, service and maintenance contracts, and licensing fees. Significant partnerships with industry leaders and integration of their solutions into broader enterprise systems further support revenue growth. Additionally, Antares Vision benefits from long-term relationships with global manufacturers across various industries, contributing to recurring revenue through service agreements and system upgrades.

Antares Vision SpA Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Income Statement		Total Revenue
210.02M	224.06M	179.13M	121.11M	122.20M
	Gross Profit
131.94M	122.74M	94.60M	93.32M	91.51M
	EBIT
-91.36M	17.01M	17.72M	19.92M	31.93M
	EBITDA
-68.77M	22.12M	30.59M	25.06M	32.83M
	Net Income Common Stockholders
-99.65M	18.20M	12.40M	18.16M	21.92M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
56.61M	87.92M	118.48M	129.19M	118.33M
	Total Assets
436.44M	581.99M	507.61M	362.92M	297.09M
	Total Debt
163.99M	149.56M	137.71M	158.45M	107.77M
	Net Debt
120.62M	88.46M	59.38M	62.41M	22.57M
	Total Liabilities
268.72M	273.14M	235.21M	227.76M	179.35M
	Stockholders Equity
167.81M	308.75M	272.33M	134.83M	117.15M
Cash Flow		Free Cash Flow
-23.99M	-28.07M	13.32M	9.12M	7.33M
	Operating Cash Flow
-6.79M	-10.47M	29.82M	16.06M	10.70M
	Investing Cash Flow
-9.99M	-22.14M	-136.76M	-54.84M	-81.48M
	Financing Cash Flow
-3.07M	14.39M	88.37M	50.13M	116.67M

Antares Vision SpA Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3.51
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IT:AV, the sentiment is Positive. The current price of 3.51 is above the 20-day moving average (MA) of 3.25, above the 50-day MA of 3.41, and above the 200-day MA of 3.23, indicating a bullish trend. The MACD of 0.03 indicates Negative momentum. The RSI at 62.24 is Neutral, neither overbought nor oversold. The STOCH value of 92.12 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IT:AV.

Antares Vision SpA Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
WIIT	73 Outperform	€435.79M	46.58	27.87%	2.03%	20.24%	12.52%
TXT	72 Outperform	€389.94M	26.76	12.06%	0.76%	35.72%	0.10%
ERG	67 Neutral	€2.69B	14.06	8.74%	5.54%	-0.39%	6.12%
Sector *	64 Neutral	$4.28B	11.80	5.33%	250.46%	4.10%	-9.26%
AV	51 Neutral	€249.59M	―		―	-1.20%	―
SFER	47 Neutral	€859.03M	112.46	-10.16%	1.79%	-10.48%	-360.89%

Antares Vision SpA Corporate Events

Antares Vision Releases Annual Financial Report Ahead of Shareholders’ Meeting

Antares Vision S.p.A. has made available its annual financial report and other relevant documentation for the upcoming shareholders’ meeting on July 10, 2024. This includes the annual financial report, corporate governance report, remuneration policy report, and explanatory reports on agenda items, which are accessible on the company’s website and other authorized platforms.

Antares Vision Issues Correction for Shareholders’ Meeting Documentation

Antares Vision S.p.A. has released a correction regarding the explanatory report for the shareholders’ meeting scheduled for May 7, 2025. The correction pertains to the allocation of the operating result in one of the proposed resolutions, which could impact shareholder decisions and company operations.

Antares Vision Publishes Updated Articles of Association and Board Meeting Minutes

Antares Vision S.p.A. has announced the publication of the minutes from its Board of Directors meeting held on March 25, 2025, which includes a resolution to increase share capital. The updated Articles of Association reflecting these changes are now available on the company’s website and other authorized platforms, marking a significant step in the company’s financial strategy.

Antares Vision S.p.A. Announces Shareholders’ Meeting to Discuss 2024 Financials and Strategic Initiatives

Antares Vision S.p.A. has announced a shareholders’ meeting scheduled for May 7, 2025, to discuss various financial and strategic initiatives. Key agenda items include the approval of the 2024 financial statements, a new long-term stock incentive plan, and proposals for capital increases to support employee incentives, reflecting the company’s commitment to growth and stakeholder engagement.

Antares Vision Group Unveils Ambitious 2025-2027 Business Plan

Antares Vision Group has unveiled its 2025-2027 business plan, focusing on accelerating growth and enhancing profitability. The plan aims for a revenue growth CAGR of 7-9% and an EBITDA CAGR of 18-21%, with strategic initiatives including a commercial excellence program, cost efficiency, and cash generation. The company also plans to strengthen its market leadership, capitalize on emerging market opportunities, and implement an ESG strategy.

Antares Vision’s Parent Company Shareholders Sign New Governance Agreement

A shareholders’ agreement has been signed by Dorado S.r.l., Emidio Zorzella, Massimo Bonardi, and ForeHolding S.r.l., concerning the limitations on the disposal of shares owned by ForeHolding in Regolo S.p.A., which controls Antares Vision S.p.A., an Italian company with listed shares. This agreement, which involves 73% of Regolo’s share capital, aligns with relevant legal and regulatory provisions and aims to ensure appropriate shareholder governance and compliance.

Antares Vision Exceeds 2024 Targets with Strong Q4 Performance

Antares Vision Group reported strong financial performance for the fourth quarter of 2024, surpassing its targets for the year. The company saw a notable increase in orders, particularly in Europe and the Americas, and significant growth in revenue, driven by enhancements in processes and a strategic focus on cash generation and R&D.

Antares Vision Group Partners with Guinea-Bissau for Pharmaceutical System Overhaul

Antares Vision Group has entered into a strategic agreement with the Ministry of Health of Guinea-Bissau to implement a national pharmaceutical traceability system and a digital drug catalog. This initiative aims to modernize Guinea-Bissau’s healthcare infrastructure by improving drug traceability, regulatory compliance, and supply chain integrity. It positions Guinea-Bissau at the forefront of pharmaceutical verification in West Africa, enhancing patient safety and regulatory oversight through advanced technology and data management solutions.